Literature DB >> 22625186

Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation.

Stefan Stortecky1, Andreas W Schoenenberger2, André Moser3, Bindu Kalesan3, Peter Jüni3, Thierry Carrel4, Seraina Bischoff1, Christa-Maria Schoenenberger1, Andreas E Stuck2, Stephan Windecker5, Peter Wenaweser1.   

Abstract

OBJECTIVES: This study evaluated Multidimensional Geriatric Assessment (MGA) as predictor of mortality and major adverse cardiovascular and cerebral events (MACCE) after transcatheter aortic valve implantation (TAVI).
BACKGROUND: Currently used global risk scores do not reliably estimate mortality and MACCE in these patients.
METHODS: This prospective cohort comprised 100 consecutive patients ≥ 70 years undergoing TAVI. Global risk scores (Society of Thoracic Surgeons [STS] score, EuroSCORE) and MGA-based scores (cognition, nutrition, mobility, activities of daily living [ADL], and frailty index) were evaluated as predictors of all-cause mortality and MACCE 30 days and 1 year after TAVI in regression models.
RESULTS: In univariable analyses, all predictors were significantly associated with mortality and MACCE at 30 days and 1 year, except for the EuroSCORE at 30 days and instrumental ADL at 30 days and 1 year. Associations of cognitive impairment (odds ratio [OR]: 2.98, 95% confidence interval [CI]: 1.07 to 8.31), malnutrition (OR: 6.72, 95% CI: 2.04 to 22.17), mobility impairment (OR: 6.65, 95% CI: 2.15 to 20.52), limitations in basic ADL (OR: 3.63, 95% CI: 1.29 to 10.23), and frailty index (OR: 3.68, 95% CI: 1.21 to 11.19) with 1-year mortality were similar compared with STS score (OR: 5.47, 95% CI: 1.48 to 20.22) and EuroSCORE (OR: 4.02, 95% CI: 0.86 to 18.70). Similar results were found for 30-day mortality and MACCE. Bivariable analyses, including STS score or EuroSCORE suggested independent associations of MGA-based scores (e.g., OR of frailty index: 3.29, 95% CI: 1.06 to 10.15, for 1-year mortality in a model including EuroSCORE).
CONCLUSIONS: This study provides evidence that risk prediction can be improved by adding MGA-based information to global risk scores. Larger studies are needed for the development and validation of improved risk prediction models.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22625186     DOI: 10.1016/j.jcin.2012.02.012

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  61 in total

Review 1.  Futility, benefit, and transcatheter aortic valve replacement.

Authors:  Brian R Lindman; Karen P Alexander; Patrick T O'Gara; Jonathan Afilalo
Journal:  JACC Cardiovasc Interv       Date:  2014-06-18       Impact factor: 11.195

2.  The impact of frailty on mortality after transcatheter aortic valve replacement.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Kianoush Kashani
Journal:  Ann Transl Med       Date:  2017-03

3.  Symptomatic severe aortic stenosis in the TAVI era: heart team assessment for all.

Authors:  P C Kievit
Journal:  Neth Heart J       Date:  2012-12       Impact factor: 2.380

4.  Perioperative frailty.

Authors:  Levana G Amrock; Stacie Deiner
Journal:  Int Anesthesiol Clin       Date:  2014

5.  Frail Elderly, the Ideal Patients for MitraClip.

Authors:  Suzanne V Arnold
Journal:  JACC Cardiovasc Interv       Date:  2017-10-09       Impact factor: 11.195

Review 6.  Frailty in cardiothoracic surgery: systematic review of the literature.

Authors:  Hiroshi Furukawa; Kazuo Tanemoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-28

7.  Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.

Authors:  Harun Kundi; Linda R Valsdottir; Jeffrey J Popma; David J Cohen; Jordan B Strom; Duane S Pinto; Changyu Shen; Robert W Yeh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-10

Review 8.  Frailty, Aging, and Cardiovascular Surgery.

Authors:  Antonio Graham; Charles H Brown
Journal:  Anesth Analg       Date:  2017-04       Impact factor: 5.108

Review 9.  Frailty assessment in the cardiovascular care of older adults.

Authors:  Jonathan Afilalo; Karen P Alexander; Michael J Mack; Mathew S Maurer; Philip Green; Larry A Allen; Jeffrey J Popma; Luigi Ferrucci; Daniel E Forman
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

Review 10.  Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations.

Authors:  Dae Hyun Kim; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-06-24       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.